Alpha 2.0
Login Register
» Articles » PMID: 24516302

Report of Chronic Myeloid Leukemia in Chronic Phase from Eastern India, Institute of Hematology and Transfusion Medicine, Kolkata, 2001-2009

Overview
Journal Indian J Med Paediatr Oncol
Publisher Thieme
Specialty Oncology
Date 2014 Feb 12
PMID 24516302
Citations 2
Authors
Siddhartha Sankar Ray
Prantar Chakraborty
Utpal Chaudhuri
Ganesh
Affiliations
Soon will be listed here.
Abstract

The data 192 patients from Eastern India, Kolkata center was presented in Indian cooperative oncology network meeting, out of which 97% patients were diagnosed in the chronic phase. Complete hematological response was seen in 70.5% among patients and 86% of patients were in clinical and hematological remission over 5 years with a median follow-up of 4.85 years.

Citing Articles

Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India.

Phukan A, Mandal P, Dolai T Ann Hematol. 2020; 100(1):85-96.

PMID: 33025163 DOI: 10.1007/s00277-020-04289-8.

Summary of the published Indian data on chronic myeloid leukemia.

Singhal M, Sengar M, Nair R South Asian J Cancer. 2016; 5(3):162-5.

PMID: 27606306 PMC: 4991141. DOI: 10.4103/2278-330X.187593.

References
1.
Lee S . Chronic myelogenous leukaemia. Br J Haematol. 2001; 111(4):993-1009. DOI: 10.1046/j.1365-2141.2000.02216.x. View
2.
Jabbour E, Cortes J, Kantarjian H . Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: what is the optimal strategy?. Mayo Clin Proc. 2009; 84(2):161-9. PMC: 2664587. DOI: 10.4065/84.2.161. View
3.
Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J . Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009; 27(35):6041-51. PMC: 4979100. DOI: 10.1200/JCO.2009.25.0779. View